During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...
FRIDAY, Oct. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax ...
To discourage price hikes on brand-name drugs, the IRA requires manufacturers to pay inflation rebates to Medicare if prices ...
HealthDay on MSN
FDA announces plans to relax rules about copycat drugs
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
Andel is a revolution in drug affordability — a cooperative employee platform that unlocks access to GLP-1s and other ...
President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs ...
For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...
Cipla will market Eli Lilly's weight loss drug Yurpeak in India, manufactured by Lilly, offering personalized treatment ...
Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback